Vertex Pharmaceuticals (VRTX)

P/S ratio as of April 2025 (TTM): 11.5

According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.71. At the end of 2024 the company had a P/S ratio of 9.55.

P/S ratio history for Vertex Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	9.55	-10.09%
2023	10.6	27.99%
2022	8.30	12.49%
2021	7.38	-25.49%
2020	9.90	-27.3%
2019	13.6	-1.82%
2018	13.9	-8.89%
2017	15.2	41.87%
2016	10.7	-64.24%
2015	30.0	-39.33%
2014	49.5	245.26%
2013	14.3	140.39%
2012	5.96	21.42%
2011	4.91	-90.13%
2010	49.7	-40.87%
2009	84.1	243.25%
2008	24.5	57.95%
2007	15.5	-28.9%
2006	21.8	17.27%
2005	18.6	123.8%
2004	8.31	-31.45%
2003	12.1	61.36%
2002	7.51	-46.1%
2001	13.9

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Gilead Sciences GILD	4.61	-59.85%	🇺🇸 USA
AbbVie ABBV	5.56	-51.60%	🇺🇸 USA
Merck MRK	3.09	-73.12%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.04	-82.20%	🇺🇸 USA
Johnson & Johnson JNJ	4.22	-63.30%	🇺🇸 USA
Enanta Pharmaceuticals ENTA	1.79	-84.38%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Vertex Pharmaceuticals (VRTX)

P/S ratio as of April 2025 (TTM): 11.5